0001104659-18-018705.txt : 20180319
0001104659-18-018705.hdr.sgml : 20180319
20180319203017
ACCESSION NUMBER: 0001104659-18-018705
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20180319
DATE AS OF CHANGE: 20180319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaseta Michael
CENTRAL INDEX KEY: 0001724346
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37691
FILM NUMBER: 18700432
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N OE4
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aralez Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660719
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
BUSINESS PHONE: 905-876-1118
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
4
1
a4.xml
4
X0306
4
2018-03-15
0
0001660719
Aralez Pharmaceuticals Inc.
ARLZ
0001724346
Kaseta Michael
C/O ARALEZ PHARMACEUTICALS INC.,
7100 WEST CREDIT AVENUE, SUITE 101
MISSISSAUGA
A6
L5N 0E4
ONTARIO, CANADA
0
1
0
0
Chief Financial Officer
Common Shares, without par value
2018-03-15
4
A
0
12500
0
A
15000
D
Employee Stock Option (right to buy)
1.75
2018-03-15
4
A
0
25000
0
A
2028-03-15
Common Shares, without par value
25000
25000
D
Restricted Stock Units granted pursuant to the Aralez Pharmaceuticals Inc. 2016 Amended and Restated Long-Term Incentive Plan, which vest 33.3% annually over three years commencing upon the first anniversary of the date of grant, subject to continued employment or service to the Company.
Includes 833 shares of Common Stock and 14,167 Restricted Stock Units.
The option vests as to 25% of the shares on March 15, 2019, and the remainder vests in substantially equal monthly installments over the 36 months immediately following such date, subject to continued employment or service to the Company.
/s/ Michael Kaseta
2018-03-19